FPAS
EDIT icon

Focus Partners Advisor Solutions’s Editas Medicine EDIT Stock Holding History

Focus Partners Advisor Solutions’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,806
Closed -$36.6K – 1294
2026
Q1 		$36.6K Buy
+14,806
New +$31.3K ﹤0.01% 1230
2025
Q4 		– Sell
-11,164
Closed -$36.3K – 1142
2025
Q3 		$36.3K Sell
11,164
-3,597
-24% -$10K ﹤0.01% 1119
2025
Q2 		$32.5K Buy
14,761
+3,759
+34% +$6.15K ﹤0.01% 1084
2025
Q1 		$12.8K Buy
+11,002
New +$16.2K ﹤0.01% 967

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Focus Partners Advisor Solutions's EDIT Position: Q2 2026 in Review

Focus Partners Advisor Solutions sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 14,806 shares — an estimated $36.6K sold.

Focus Partners Advisor Solutions first reported a position in EDIT in Q1 2025 and held it in 4 quarters. The position peaked at $36.6K in Q1 2026. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Focus Partners Advisor Solutions reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 14,806 Editas Medicine shares in Q2 2026, an estimated $36.6K.
  • Focus Partners Advisor Solutions first reported a position in Editas Medicine in Q1 2025 and held it in 4 quarters.
  • Focus Partners Advisor Solutions's Editas Medicine position peaked at $36.6K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.